Delta-Fly Pharma, Inc. Logo

Delta-Fly Pharma, Inc.

Biopharmaceutical firm developing novel anticancer drugs from existing components.

4598 | T

Overview

Corporate Details

ISIN(s):
JP3549370009
LEI:
Country:
Japan
Address:
徳島市川内町宮島錦野37番地の5

Description

Delta-Fly Pharma, Inc. is a biopharmaceutical company specializing in the research and development of anticancer drugs. The company's core strategy is its proprietary "Module Drug Development" concept, an approach that combines existing pharmaceutical components to create novel therapeutic agents. This methodology aims to develop effective cancer treatments with significantly reduced side effects and at reasonable prices, thereby improving the quality of life for patients. The company's pipeline includes several drug candidates for various cancers, with some, such as DFP-10917 for refractory/relapsed acute myeloid leukemia, advancing to late-stage clinical trials. Delta-Fly Pharma focuses on creating gentle yet potent therapies, including nucleoside analogs and RNA therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 07:39
確認書
Japanese 8.9 KB
2025-11-14 07:35
半期報告書-第16期(2025/04/01-2026/03/31)
Japanese 206.9 KB
2025-06-27 08:44
臨時報告書
Japanese 24.4 KB
2025-06-27 08:39
内部統制報告書-第15期(2024/04/01-2025/03/31)
Japanese 23.0 KB
2025-06-27 08:34
確認書
Japanese 8.8 KB
2025-06-27 08:30
有価証券報告書-第15期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-04-14 08:30
有価証券届出書(組込方式)
Japanese 289.0 KB
2024-11-14 07:39
確認書
Japanese 8.9 KB
2024-11-14 07:36
半期報告書-第15期(2024/04/01-2025/03/31)
Japanese 180.2 KB
2024-10-07 08:00
臨時報告書
Japanese 22.6 KB
2024-09-20 08:00
有価証券届出書(組込方式)
Japanese 326.2 KB
2024-09-11 08:00
臨時報告書
Japanese 22.8 KB
2024-06-28 08:31
臨時報告書
Japanese 23.5 KB
2024-06-28 08:28
確認書
Japanese 8.8 KB
2024-06-28 08:25
内部統制報告書-第14期(2023/04/01-2024/03/31)
Japanese 22.6 KB

Automate Your Workflow. Get a real-time feed of all Delta-Fly Pharma, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Delta-Fly Pharma, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Delta-Fly Pharma, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.